Delivery Order SPE2DR25D7067-SPE2DR26FW4CA
Award Date 1/14/26
Potential Completion Date 1/15/26
Potential Value $5.6K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,948.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ACT-O-VIALS on January 15, 2026, with completion expected by January 16, 2026. This is a non-set-aside award issued as a child contract under AmerisourceBergen's parent company, Cencora, Inc. The contract specifies performance in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. AmerisourceBergen serves as a critical pharmaceutical distributor...
- On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,425.07 to AmerisourceBergen Drug Corp for ACT-O-VIALS, with an ultimate completion date of January 14, 2026. This is a firm fixed-price delivery order issued under a competitive process with no set-aside designation. The awardee, AmerisourceBergen Drug Corp, is headquartered in Conshohocken, Pennsylvania, and serves as a critical pharmaceutical distributor to federal medical procurement programs, particularly...
- On January 7, 2026, the Defense Logistics Agency awarded a delivery order valued at $19,433.50 to AmerisourceBergen Drug Corp for ACT-O-VIALS. This firm fixed-price delivery order, with an ultimate completion date of January 8, 2026, was awarded on a fully competitive basis with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,968.60 firm fixed-price delivery order for ACT-O-VIALS with an ultimate completion date of December 22, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $10,604.05 to AmerisourceBergen Drug Corp on December 11, 2025, for ACT-O-VIALS pharmaceutical products. The contract represents a firm fixed price delivery order with an ultimate completion date of December 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded through open competition. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,071.99 to AmerisourceBergen Drug Corp for ACT-O-VIALS on November 20, 2025, with an ultimate completion date of November 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery supports the DLA's medical supply chain...
- The Defense Logistics Agency awarded a $1,992.15 delivery order to AmerisourceBergen Drug Corp for ACT-O-Vials on December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,328.32 to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 19, 2025, with an ultimate completion date of December 22, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and is classified as a child contract under a larger vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $12,356.69 to AmerisourceBergen Drug Corp for Act-O-Vials on January 14, 2026, with completion scheduled for January 15, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,328.32 to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 2, 2025, with an ultimate completion date of December 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The order will be fulfilled from the contractor's Corporate Office location in Conshohocken,...